DavidScottAdamsMD

PubMed

• 20 citations
  MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis.
  Debra S Regier, Hyuk Joon Kwon, Jean M. Johnston, Gretchen Golas, Sandra Yang, Edythe Wiggs, Yvonne L. Latour, Sarah E. Thomas, Cindy Portner, David H. Adams, Gilbert ...> ;American Journal of Medical Genetics. Part A. 2016 Mar 1
• Evaluation of treatments for cyanoacrylate eyelash adhesion using an in-vitro model.
  Prouty, H., Adams, D.S., Heard, K.> ;Cutan Ocul Toxicol. 2008
• A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a fu...
  Adams, D.S., Hasson, B., Boyer-Boiteau, A., El-Khishin, A., Shashoua, V.E.> ;J Neurosci Res. 2003 May 1
• New synthetic peptides can enhance gene expression of key antioxidant defense enzymes in vitro and in vivo.
  Shashoua, V. E., Adams, D. S., Volodina, N. V., Li, H.> ;Brain Res. 2004 Oct 22
• Neuroprotective effects of a new synthetic peptide, CMX-9236, in in vitro and in vivo models of cerebral ischemia.
  Shashoua, V. E., Adams, D. S., Boyer-Boiteau, A., Cornell-Bell, A., Li, F., Fisher, M.> ;Brain Res. 2003 Feb 14
• Join now to see all